Skip to main content

Research Repository

Advanced Search

The clinical impact of serious respiratory disease in children under the age of two years during the 2021-2022 bronchiolitis season in England, Scotland and Ireland

Williams, Thomas C; Marlow, Robin; Hardelid, Pia; Lyttle, Mark D; Lewis, Kate M; Mpamhanga, Chengetai D; Cunningham, Steve; Roland, Damian

The clinical impact of serious respiratory disease in children under the age of two years during the 2021-2022 bronchiolitis season in England, Scotland and Ireland Thumbnail


Authors

Thomas C Williams

Robin Marlow

Pia Hardelid

Kate M Lewis

Chengetai D Mpamhanga

Steve Cunningham

Damian Roland



Abstract

Interventions introduced to reduce the spread of SARS-CoV-2 led to a widespread reduction in childhood infections. However, from spring 2021 onwards the United Kingdom and Ireland experienced an unusual out-of-season epidemic of respiratory disease. We conducted a prospective observational study (BronchStart), enrolling children 0-23 months of age presenting with bronchiolitis, lower respiratory tract infection or first episode of wheeze to 59 Emergency Departments across England, Scotland and Ireland from May 2021 to April 2022. We combined testing data with national admissions datasets to infer the impact of respiratory syncytial virus (RSV) disease. The BronchStart study collected data on 17,899 presentations for 17,164 children. Risk factors for admission and escalation of care included prematurity and congenital heart disease, but most admissions were for previously healthy term-born children. Of those aged 0-11 months who were admitted and tested for RSV, 1,907/3,912 (48.7%) tested positive. We estimate that every year in England and Scotland 28,561 (95% confidence interval 27,637-29,486) infants are admitted with RSV infection. RSV infection was the main cause of hospitalisations in this cohort, but 51.3% of admissions in infants were not associated with the virus. The majority of admissions were in previously healthy term-born infants. [Abstract copyright: © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.]

Journal Article Type Article
Acceptance Date Nov 28, 2023
Online Publication Date Dec 2, 2023
Publication Date Jul 15, 2024
Deposit Date Feb 7, 2024
Publicly Available Date Feb 8, 2024
Journal The Journal of infectious diseases
Print ISSN 0022-1899
Electronic ISSN 1537-6613
Publisher Oxford University Press (OUP)
Peer Reviewed Peer Reviewed
Volume 230
Issue 1
Pages e111–e120
DOI https://doi.org/10.1093/infdis/jiad551
Keywords Respiratory syncytial virus, immunisation, respiratory infections
Public URL https://uwe-repository.worktribe.com/output/11519441

Files





You might also like



Downloadable Citations